SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-11-261062
Filing Date
2011-09-30
Accepted
2011-09-30 13:11:34
Documents
1
Group Members
CLARUS VENTURES I MANAGEMENT, L.P.CLARUS VENTURES I, LLCDENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d238640dsc13d.htm SC 13D 177830
  Complete submission text file 0001193125-11-261062.txt   179710
Mailing Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 (858) 259-1165
ZOGENIX, INC. (Subject) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85795 | Film No.: 111116382
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences I, L.P. (Filed by) CIK: 0001431445 (see all company filings)

IRS No.: 203855540 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D